NZ225158A - Pharmaceutical compositions in pellet form with enzymatically controlled release of an active - Google Patents

Pharmaceutical compositions in pellet form with enzymatically controlled release of an active

Info

Publication number
NZ225158A
NZ225158A NZ225158A NZ22515888A NZ225158A NZ 225158 A NZ225158 A NZ 225158A NZ 225158 A NZ225158 A NZ 225158A NZ 22515888 A NZ22515888 A NZ 22515888A NZ 225158 A NZ225158 A NZ 225158A
Authority
NZ
New Zealand
Prior art keywords
enzyme
pharmaceutical composition
pharmaceutical
composition according
substrate
Prior art date
Application number
NZ225158A
Other languages
English (en)
Inventor
Horst-Georg Zerbe
Jorn Ullrich Becker
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of NZ225158A publication Critical patent/NZ225158A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
NZ225158A 1987-06-30 1988-06-24 Pharmaceutical compositions in pellet form with enzymatically controlled release of an active NZ225158A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873721574 DE3721574A1 (de) 1987-06-30 1987-06-30 Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung

Publications (1)

Publication Number Publication Date
NZ225158A true NZ225158A (en) 1990-12-21

Family

ID=6330589

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ225158A NZ225158A (en) 1987-06-30 1988-06-24 Pharmaceutical compositions in pellet form with enzymatically controlled release of an active

Country Status (7)

Country Link
EP (1) EP0370049A1 (ja)
JP (1) JPH02504145A (ja)
AU (1) AU618748B2 (ja)
DE (1) DE3721574A1 (ja)
NZ (1) NZ225158A (ja)
WO (1) WO1989000045A1 (ja)
ZA (1) ZA884622B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049395A (en) * 1989-03-09 1991-09-17 Micro Vesicular Systems, Inc. Controlled release vehicle
SE8901279D0 (sv) * 1989-04-10 1989-04-10 Pharmacia Ab Komposition
DE3918801A1 (de) * 1989-06-06 1991-05-08 Schmidt Walter Praeparat zur geregelten wirkstoffabgabe und verfahren zu dessen herstellung
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5603956A (en) * 1990-11-27 1997-02-18 Labopharm Inc. Cross-linked enzymatically controlled drug release
NL9201195A (nl) * 1992-07-03 1994-02-01 Tno Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.
NL9201196A (nl) * 1992-07-03 1994-02-01 Tno Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.
HU221591B (hu) * 1992-07-24 2002-11-28 Labopharm Inc. Keresztkötéses polihidroxil-származék enzimatikusan szabályozott hatóanyag-kibocsátáshoz
JPH08507700A (ja) * 1992-12-28 1996-08-20 ボシュ アンド ロム インコーポレイテッド 水性媒体内に活性物質を制御放出する組成物
ES2288152T3 (es) * 1999-08-09 2008-01-01 Dainippon Sumitomo Pharma Co., Ltd. Preparaciones solidas que contienen polvo de quitosano y procedimiento de produccion asociado.
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
FR2938433B1 (fr) * 2008-11-19 2011-09-09 Francois Fauran Compositions pharmaceutiques utilisant l'inuline comme excipient de granulation
JP6069782B2 (ja) * 2012-11-09 2017-02-01 国立大学法人佐賀大学 基質応答性自律振動型マイクロカプセル
CN113172887B (zh) * 2021-03-15 2023-04-07 中国科学院上海硅酸盐研究所 一种具有缓释功能的同轴支架材料

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493652A (en) * 1962-09-14 1970-02-03 Charles W Hartman Controlled release medicament
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4261969A (en) * 1979-05-03 1981-04-14 World Health Organization Controlled drug release composition
DE2923279C2 (de) * 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
JPS5640151A (en) * 1979-09-06 1981-04-16 Daiichi Seiyaku Co Coating device for tablet
WO1983003061A1 (en) * 1982-03-04 1983-09-15 Battelle Development Corp Dual microcapsules
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom

Also Published As

Publication number Publication date
DE3721574A1 (de) 1989-01-12
AU2124588A (en) 1989-01-30
JPH02504145A (ja) 1990-11-29
ZA884622B (en) 1990-02-28
WO1989000045A1 (en) 1989-01-12
EP0370049A1 (en) 1990-05-30
AU618748B2 (en) 1992-01-09

Similar Documents

Publication Publication Date Title
JP4749639B2 (ja) 味がマスクされ、活性成分を即時放出する、被覆された顆粒の製造方法
JP4088420B2 (ja) 多糖類を利用した大腸選択性薬物伝達組成物および医薬製剤
US6312728B1 (en) Sustained release pharmaceutical preparation
US5422121A (en) Oral dosage unit form
US5294448A (en) Delayed release formulations
JP5685542B2 (ja) 結腸ターゲッティング用の水不溶性ポリマー：デンプン系フィルムコーティング
JP3806740B2 (ja) 薬剤運搬組成物
US6068859A (en) Controlled-release dosage forms of Azithromycin
JP2773959B2 (ja) 大腸内放出性固形製剤
NZ225158A (en) Pharmaceutical compositions in pellet form with enzymatically controlled release of an active
US5540945A (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
US20030161874A1 (en) Controlled release oral dosage form
US20020160046A1 (en) Delivery system for omeprazole and its salts
JP2001527023A (ja) 胃で保持するのに適合した長期放出性活性剤剤形
JPH08506802A (ja) 波状粒薬配給システム
US5776489A (en) Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
EP0264989B1 (en) Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
EP1109535B1 (en) Extended release acetaminophen
US4954349A (en) Oral magnesium and potassium compositions and use
CA2634006C (en) Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine
GB2209668A (en) Oral magnesium and potassium compositions
EP0540813B1 (en) Sustained release formulations of acetazolamide
JP3456211B2 (ja) 持続性製剤
CA2685214A1 (en) Improved controlled release oral dosage form
JPH05112469A (ja) 多孔性担体及びこれを用いた製剤、並びにそれらの製造方法